NCMP-08. CHALLENGING DIAGNOSIS AND MANAGEMENT OF PCNSL IN AN IMMUNOSUPPRESSED PATIENT ON MYCOPHENOLATE MOFETIL FOR MYASTHENIA GRAVIS
Bricoune O, Mokhtari S, Etame A, Robinson T, Pina Y, Macaulay R. NCMP-08. CHALLENGING DIAGNOSIS AND MANAGEMENT OF PCNSL IN AN IMMUNOSUPPRESSED PATIENT ON MYCOPHENOLATE MOFETIL FOR MYASTHENIA GRAVIS. Neuro-Oncology 2021, 23: vi148-vi149. DOI: 10.1093/neuonc/noab196.581.Peer-Reviewed Original ResearchPrimary CNS lymphomaDiffuse large B-cell lymphomaMycophenolate mofetilMyasthenia gravisEnhancing lesionsBrain MRIAcetylcholine receptor antibody-positive myasthenia gravisDiagnosis of PCNSLManagement of PCNSLAntibody-positive myasthenia gravisLarge B-cell lymphomaLeft eye visionRepeat brain MRIFocal neurological deficitsCerebrospinal fluid analysisPositive myasthenia gravisGross total resectionPeriventricular white matterLeft frontal lesionNew enhancing lesionsAdditional diagnostic testsB-cell lymphomaLeft medullaOral prednisoneRituximab IV